{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Method - Health in the Real World","title":"Ep. 17 - Rethinking type 2 diabetes: genetics, lifestyle, and a new era for treatment, with Dr. Naveed Sattar","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/03434db5\"></iframe>","width":"100%","height":180,"duration":2854,"description":"Type 2 diabetes is a disease on the rise. It affects over 4 million people in the UK, with many living with it undiagnosed. So how can we recognise the signs, reduce our risks, or better live with it? \nThis week, Greg and Charlie put these questions to Dr. Naveed Sattar, Professor of Cardiometabolic Medicine at the University of Glasgow and one of the world's most cited researchers in diabetes and obesity science. With over 1,400 peer-reviewed publications, a career spent working directly with patients, and his own first-hand experience of living with an elevated risk of diabetes, Naveed is a voice to be reckoned with on this subject.\n\nStarting with the science, Naveed will explain what happens inside the body when we develop type 2 diabetes: why it’s different from type 1, and how ectopic fat (fat that gets stored around our middle and in non-fat organs like the liver or pancreas) hinders insulin production. We talk about the genetic and environmental factors that heighten our risks, and about why certain populations are more vulnerable. \nYou will see that when it comes to diabetes, the science has changed over the last decade: moving away from focusing on sugar, toward prioritising weight loss instead, with GLP-1 medications like Ozempic and Wegovy playing a part.\nIn our practice segment, Naveed, Greg, and Charlie get into what this all means for day-to-day life. Including:\nHow Naveed changed his lifestyle after being diagnosed at risk (23:21)\nScreening and testing for diabetes (27:33)\nThe role of movement in reducing risks (30:05)\nWhere and how GLP-1 medications get factored in (33:39)\n\nFinally, in the experience section, we turn to your listener questions. We hear from those navigating gestational diabetes, and from people who have been living with type 2 diabetes or are trying to lower their risks.\nIf you take only one thing away from this episode, remember that a type 2 diabetes diagnosis is not the result of lifestyle choices. This episode is for anyone...","thumbnail_url":"https://img.transistorcdn.com/c6ypnx0JQE1JWxTnltulvgV2WOBVgiujrfWR7NGWuFo/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80YjM5/NmQzNmM1MTQ3M2Zi/ZWFhZmU2NzQ3MDNm/ZjU5MC5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}